Cramer Pamela J.'s Form 4 filing
Rhythm Pharmaceuticals, Inc. (RYTM) · filed Feb 13, 2023
- Accession no.
- 0001104659-23-019818
- Filed
- Feb 13, 2023
- Trade date
- Feb 9, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $23.1K. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001104659-23-022073 (Feb 14, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cramer Pamela J.CIK 0001873517 | Officer (Chief Human Resources Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2023 | Common Stock | MOption exerciseAcquired | +2,344 | –F1 | – | 6,985 | Direct | |
| Feb 9, 2023 | Common Stock | SSaleDisposed | −834 | $27.66 | −$23,068.44 | 6,151 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2023 | Common Stock | MOption exerciseDisposed | −2,344 | $0.00 | $0 | 7,031 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
Referenced by the price of 1 transaction in Table I.